GRFS logo

Grifols, S.A. (GRFS)

Profile

Full Name

Grifols, S.A.

Ticker

NASDAQ: GRFS

Exchange

NASDAQ

Sector

Healthcare

Industry

General Drug Manufacturers

Country

Spain

IPO

June 2, 2011

Indexes

Not included

Website

http://www.grifols.com

Employees

23800

Key Details

Price

$10.10(+1.61%)

Market cap

$6.87B(Mid cap)

Last Dividend

$0.46

TTM Dividend yield

-

Annual revenue

$7.81B(+9.39% YoY)

Annual EPS

$0.25(+282.92% YoY)

PE ratio

47.40

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.10
    GRFS price is $10.10

    30-Day Relative Volume

    0.79
    GRFS 30-day relative volume is 0.79

    Price Performance

    Price Most recent change

    +1.61%
    GRFS price was up +1.61% on Jul 25, 2025

    Price YTD change

    +35.75%
    GRFS price is up +35.75% since January 1st

    Price 1-year change

    +29.82%
    GRFS price is up +29.82% year-on-year

    Price 3-year change

    -4.36%
    GRFS price is down -4.36% over the past 3 years

    Price Range

    Price All-time high

    $25.73
    GRFS price is currently -60.75% below its historical high of $25.73

    Price 3-year low

    $5.30
    GRFS price is currently +90.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $6.87B
    GRFS market capitalization is $6.87 billion

    Market cap 3-year change

    -4.14%
    GRFS market capitalization is down -4.14% over the past 3 years

    Market cap All-time high

    $22.04B
    GRFS market capitalization is currently -68.81% below its historical high of $22.04 billion

    Market cap sector rank

    90.11%
    GRFS market capitalization is higher than 90.11% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.11%
    GRFS shares outstanding is up +0.11% year-on-year

    Shares Outstanding 3-Year Change

    +0.22%
    GRFS shares outstanding is up +0.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.87
    GRFS beta is 0.87

    200-day SMA

    $8.05
    GRFS price is currently +25.54% above its 200-day simple moving average

    50-day SMA

    $8.89
    GRFS price is currently +13.58% above its 50-day simple moving average

    RSI

    67.22
    GRFS 14-day relative strength index is 67.22

    Volume

    0.79
    GRFS 30-day relative volume is 0.79

    ATR

    $0.28
    GRFS average true range is $0.28

    10-day Historical Volatility

    29.08%
    GRFS 10-day historical volatility is 29.08%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.46
    GRFS last dividend was $0.46 per share, with an ex-dividend date of June 3, 2021

    Next Dividend

    -
    GRFS next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    GRFS annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    GRFS annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    GRFS annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    GRFS annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    GRFS annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    GRFS annual dividend yield is unknown

    Other

    Payout ratio

    0.61%
    GRFS annual payout ratio is 0.61%

    Dividends paid

    $1.04M
    GRFS annual dividends paid is $1.04 million

    Free cash flow

    $574.51M
    GRFS annual free cash flow is $574.51 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $7.81B
    GRFS annual revenue is $7.81 billion

    Revenue Analysts estimate

    $7.56B
    GRFS annual revenue is currently +3.20% higher than the consensus analysts' forecast

    Revenue 1-year change

    +9.39%
    GRFS annual revenue is up +9.39% year-on-year

    Revenue Sector rank

    93.14%
    GRFS annual revenue is higher than 93.14% of companies in Healthcare sector

    EPS

    EPS

    $0.25
    GRFS annual earnings per share is $0.25

    EPS Analysts estimate

    $0.96
    GRFS annual earnings per share is currently -74.10% lower than the consensus analysts' forecast

    EPS 1-year change

    +282.92%
    GRFS annual earnings per share is up +282.92% year-on-year

    EPS Sector rank

    84.98%
    GRFS annual earnings per share is higher than 84.98% of companies in Healthcare sector

    Profit

    Gross profit

    $3.02B
    GRFS annual gross profit is $3.02 billion

    Gross margin

    38.75%
    GRFS annual gross profit margin is 38.75%

    Operating profit

    $1.25B
    GRFS annual operating income is $1.25 billion

    Operating margin

    16.02%
    GRFS annual operating profit margin is 16.02%

    Net income

    $169.84M
    GRFS annual net profit is $169.84 million

    Net margin

    2.18%
    GRFS annual net profit margin is 2.18%

    Expenses

    Total expenses

    $6.56B
    GRFS annual total expenses is $6.56 billion

    Operating expenses

    $1.77B
    GRFS annual total operating expenses is $1.77 billion

    Cost of goods sold

    $4.78B
    GRFS annual cost of goods sold is $4.78 billion

    Selling, general & administrative expenses

    $1.36B
    GRFS annual SGA is $1.36 billion

    Depreciation and amortization

    $473.96M
    GRFS annual depreciation & amortization is $473.96 million

    Interest expense

    $652.19M
    GRFS annual interest expense is $652.19 million

    Income tax

    $250.23M
    GRFS annual income tax is $250.23 million

    EBIT & EBITDA

    EBIT

    $1.13B
    GRFS annual earnings before interest & taxes is $1.13 billion

    EBITDA

    $1.61B
    GRFS annual EBITDA is $1.61 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $22.27B
    GRFS annual total assets is $22.27 billion

    Non current assets

    $16.31B
    GRFS annual long term assets is $16.31 billion

    Current assets

    $5.96B
    GRFS annual total current assets is $5.96 billion

    Cash and cash equivalents

    $1.02B
    GRFS annual cash & cash equivalents is $1.02 billion

    Accounts receivable

    $734.07M
    GRFS annual accounts receivable is $734.07 million

    Inventory

    $3.70B
    GRFS annual inventory is $3.70 billion

    Liabilities

    Total liabilities

    $13.32B
    GRFS annual total liabilities is $13.32 billion

    Long term liabilities

    $11.07B
    GRFS annual total long term liabilities is $11.07 billion

    Current liabilities

    $2.24B
    GRFS annual total current liabilities is $2.24 billion

    Accounts payable

    $886.88M
    GRFS annual accounts payable is $886.88 million

    Debt

    Total debt

    $10.49B
    GRFS annual total debt is $10.49 billion

    Total debt 1-year change

    -12.82%
    GRFS annual total debt is down -12.82% year-on-year

    Long term debt

    $9.83B
    GRFS annual long term debt is $9.83 billion

    Short term debt

    $658.42M
    GRFS annual short term debt is $658.42 million

    Equity & Capital

    Shareholders equity

    $6.12B
    GRFS annual stockholders equity is $6.12 billion

    Book value

    $6.12B
    GRFS annual book value is $6.12 billion

    Retained earnings

    $163.29M
    GRFS annual retained earnings is $163.29 million

    Working capital

    $3.72B
    GRFS annual working capital is $3.72 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $976.46M
    GRFS annual cash flow from operations is $976.46 million

    Cash from operations 1-year change

    +333.04%
    GRFS annual cash flow from operations is up +333.04% year-on-year

    Cash from investing

    $959.68M
    GRFS annual cash flow from investing activities is $959.68 million

    Cash from investing 1-year change

    +322.93%
    GRFS annual cash flow from investing activities is up +322.93% year-on-year

    Cash from financing

    -$1.47B
    GRFS annual cash flow from financing activities is -$1.47 billion

    Cash from financing 1-year change

    -830.14%
    GRFS annual cash flow from financing activities is down -830.14% year-on-year

    CAPEX

    CAPEX

    $401.95M
    GRFS annual capital expenditures is $401.95 million

    CAPEX 1-year change

    +19.64%
    GRFS annual capital expenditures is up +19.64% year-on-year

    Free Cash Flow

    Free cash flow

    $574.51M
    GRFS annual free cash flow is $574.51 million

    Free cash flow 1-year change

    +709.01%
    GRFS annual free cash flow is up +709.01% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    38.75%
    GRFS annual gross profit margin is 38.75%

    Operating margin

    16.02%
    GRFS annual operating profit margin is 16.02%

    Net margin

    2.18%
    GRFS annual net profit margin is 2.18%

    ROA & ROE

    ROA

    0.75%
    GRFS annual return on assets is 0.75%

    ROE

    1.97%
    GRFS annual return on equity is 1.97%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    47.40
    GRFS price to earnings ratio is 47.40

    PE ratio Sector rank

    76.89%
    GRFS price to earnings ratio is higher than 76.89% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.12
    GRFS price to book ratio is 1.12

    PB ratio Sector rank

    39.87%
    GRFS price to book ratio is higher than 39.87% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.14
    GRFS price to sales ratio is 1.14

    PS ratio Sector rank

    26.27%
    GRFS price to sales ratio is higher than 26.27% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $16.35B
    GRFS enterprise value is $16.35 billion

    Enterprise value Sector rank

    93.99%
    GRFS enterprise value is higher than 93.99% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    12.75
    GRFS EV/EBITDA is 12.75

    EV/EBITDA Sector rank

    86.18%
    GRFS EV/EBITDA is higher than 86.18% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.66
    GRFS annual current ratio is 2.66

    Quick ratio

    1.01
    GRFS annual quick ratio is 1.01

    Leverage

    Debt to equity

    1.53
    GRFS annual debt to equity ratio is 1.53

    Interest coverage ratio

    1.74
    GRFS annual interest coverage ratio is 1.74

    Risk & Stability

    Piotroski F-Score

    -
    GRFS piotroski f-score value is unknown

    Altman Z-Score

    1.04
    GRFS altman z-score is 1.04

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 JP Morgan
    Neutral
    Mar 12, 24 Deutsche Bank
    Sell
    Dec 5, 23 JP Morgan
    Neutral
    Nov 5, 21 Deutsche Bank
    Hold
    Mar 23, 21 Credit Suisse
    Outperform
    Mar 11, 21 HSBC
    Buy
    Oct 28, 19 Santander
    Buy
    Jun 27, 19 JP Morgan
    Overweight
    Feb 8, 19 Berenberg
    Hold
    Jan 2, 19 Morgan Stanley
    Underweight

    Institutional Ownership

    Screeners with GRFS included

    Growing Shares Outstanding
    Mid cap stocks
    Best performing stocks last month
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks YTD
    Ex Dividend dates calendar
    • What is the ticker symbol for Grifols, S.A.?
    • Does Grifols, S.A. pay dividends?
    • What sector is Grifols, S.A. in?
    • What industry is Grifols, S.A. in?
    • What country is Grifols, S.A. based in?
    • When did Grifols, S.A. go public?
    • Is Grifols, S.A. in the S&P 500?
    • Is Grifols, S.A. in the NASDAQ 100?
    • Is Grifols, S.A. in the Dow Jones?
    • When was Grifols, S.A.'s last earnings report?
    • When does Grifols, S.A. report earnings?

    What is the ticker symbol for Grifols, S.A.?

    The ticker symbol for Grifols, S.A. is NASDAQ:GRFS

    Does Grifols, S.A. pay dividends?

    No, Grifols, S.A. does not pay dividends

    What sector is Grifols, S.A. in?

    Grifols, S.A. is in the Healthcare sector

    What industry is Grifols, S.A. in?

    Grifols, S.A. is in the General Drug Manufacturers industry

    What country is Grifols, S.A. based in?

    Grifols, S.A. is headquartered in Spain

    When did Grifols, S.A. go public?

    Grifols, S.A.'s initial public offering (IPO) was on June 2, 2011

    Is Grifols, S.A. in the S&P 500?

    No, Grifols, S.A. is not included in the S&P 500 index

    Is Grifols, S.A. in the NASDAQ 100?

    No, Grifols, S.A. is not included in the NASDAQ 100 index

    Is Grifols, S.A. in the Dow Jones?

    No, Grifols, S.A. is not included in the Dow Jones index

    When was Grifols, S.A.'s last earnings report?

    Grifols, S.A.'s most recent earnings report was on May 12, 2025

    When does Grifols, S.A. report earnings?

    The next expected earnings date for Grifols, S.A. is July 30, 2025
    On this page